Homology Medicines Inc logo

Homology Medicines Inc (FIXX)

Delisted
25 Mar 2024
NASDAQ (NGS) NASDAQ (NGS)
$
0. 93
+0.01
+0.7654%
$
3.02M Market Cap
- P/E Ratio
- Div Yield
401,467 Volume
-1.98 Eps
$ 0.93
Previous Close
Investors:
Day Range
0.9 0.97
Year Range
0.9 26.64
Want to track FIXX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Homology Medicines Inc (FIXX) Statistics

Valuation metrics

Market Cap 3.02M
Enterprise value 131.16M
Trailing P/E (ttm) 4.91
Forward P/E -1.34
PEG ratio 0.02
Price/Sales (ttm) 3.13
Price/Book (mrq) 4.01
Enterprise Value/Revenue 2.44
Enterprise Value/EBITDA 5.92

Overview

Shares outstanding 3.23M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 368.07K
Average volume (90 days) 744.13K

Price summary

52-Week low 0.9
52-Week high 26.64
Beta -
50-Day moving average 9.78
200-Day moving average 5.91

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:18
Last split Date 25 Mar 2024

Financials

Fiscal year

Fiscal year ends 31 Dec 2023
Most recent quarter (mrq) 31 Dec 2023

Profitability

Profit margin 0.62%
Operating margin 0.4%

Operational effectiveness

Return on assets 0.52%
Return on equity 2.31%

Income Statement

Revenue (ttm) 1.16M
Revenue per share (ttm) 3.81
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -112.96M
Diluted EPS (ttm) 2.36
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) 749K
Total cash per share (mrq) 3.6
Total debt (mrq) 1.32M
Total Debt/Equity (mrq) 0.29
Current ratio (mrq) 5.36%
Book value per share (mrq) 3.29

Cash Flow

Cash flow statement -112.37M
Levered free cash flow (LFCF) -112.96M